- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.72 Å
- Oligo State
- hetero-3-2-2-mer
- Ligands
- 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-FUC.4: 10 residues within 4Å:- Chain A: H.336, F.339, N.340, F.368
- Chain F: Y.100, D.115
- Chain G: L.47, Y.50, R.55, A.56
5 PLIP interactions:3 interactions with chain G, 2 interactions with chain F- Hydrophobic interactions: G:L.47, G:Y.50, G:A.56
- Hydrogen bonds: F:D.115, F:D.115
NAG-NAG-BMA-FUC.8: 8 residues within 4Å:- Chain B: H.336, F.339, N.340
- Chain D: Y.32, Y.100, D.115
- Chain E: Y.50, R.55
1 PLIP interactions:1 interactions with chain D- Hydrophobic interactions: D:D.115
- 45 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
NAG.12: 4 residues within 4Å:- Chain A: F.56, N.58, S.254, W.255
Ligand excluded by PLIPNAG.13: 1 residues within 4Å:- Chain A: N.71
Ligand excluded by PLIPNAG.14: 3 residues within 4Å:- Chain A: N.119, A.120, N.122
Ligand excluded by PLIPNAG.15: 2 residues within 4Å:- Chain A: N.146, R.149
Ligand excluded by PLIPNAG.16: 2 residues within 4Å:- Chain A: N.161, N.162
Ligand excluded by PLIPNAG.17: 7 residues within 4Å:- Chain A: T.105, N.231, T.233
- Chain C: R.454, S.456, E.462, D.464
Ligand excluded by PLIPNAG.18: 3 residues within 4Å:- Chain A: N.277, E.278, N.279
Ligand excluded by PLIPNAG.19: 10 residues within 4Å:- Chain A: Q.406, A.408, G.410, Q.411, T.412, A.416, K.421, L.422, D.424, P.460
Ligand excluded by PLIPNAG.20: 1 residues within 4Å:- Chain A: N.600
Ligand excluded by PLIPNAG.21: 2 residues within 4Å:- Chain A: N.613, T.615
Ligand excluded by PLIPNAG.22: 2 residues within 4Å:- Chain A: Y.652, N.654
Ligand excluded by PLIPNAG.23: 2 residues within 4Å:- Chain A: S.705, N.706
Ligand excluded by PLIPNAG.24: 4 residues within 4Å:- Chain A: N.1095, T.1097, H.1098, F.1100
Ligand excluded by PLIPNAG.25: 1 residues within 4Å:- Chain A: N.1131
Ligand excluded by PLIPNAG.26: 1 residues within 4Å:- Chain A: N.328
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain B: Y.25, N.58
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain B: T.70, N.71
Ligand excluded by PLIPNAG.29: 1 residues within 4Å:- Chain B: N.119
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain B: Y.141, N.146, K.147
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain B: N.161, N.162
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain B: T.105, N.231, T.233
Ligand excluded by PLIPNAG.33: 3 residues within 4Å:- Chain A: K.555
- Chain B: E.278, N.279
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain B: N.328
Ligand excluded by PLIPNAG.35: 1 residues within 4Å:- Chain B: N.600
Ligand excluded by PLIPNAG.36: 4 residues within 4Å:- Chain B: N.613, T.615, E.616
- Chain C: Q.833
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Chain B: N.654
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain B: S.705, N.706
- Chain C: Y.793
Ligand excluded by PLIPNAG.39: 4 residues within 4Å:- Chain B: N.1095, T.1097, H.1098, F.1100
Ligand excluded by PLIPNAG.40: 1 residues within 4Å:- Chain B: N.1131
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain C: Y.25, N.58
Ligand excluded by PLIPNAG.42: 1 residues within 4Å:- Chain C: N.71
Ligand excluded by PLIPNAG.43: 5 residues within 4Å:- Chain C: N.119, A.120, T.121, N.122, V.124
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain C: N.146, K.147
Ligand excluded by PLIPNAG.45: 2 residues within 4Å:- Chain C: N.161, N.162
Ligand excluded by PLIPNAG.46: 5 residues within 4Å:- Chain B: E.462, D.464
- Chain C: T.105, N.231, T.233
Ligand excluded by PLIPNAG.47: 2 residues within 4Å:- Chain C: E.278, N.279
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain C: N.328, P.576, Q.577
Ligand excluded by PLIPNAG.49: 3 residues within 4Å:- Chain C: F.339, N.340, F.368
Ligand excluded by PLIPNAG.50: 1 residues within 4Å:- Chain C: N.600
Ligand excluded by PLIPNAG.51: 4 residues within 4Å:- Chain A: I.831, Q.833
- Chain C: N.613, T.615
Ligand excluded by PLIPNAG.52: 1 residues within 4Å:- Chain C: N.654
Ligand excluded by PLIPNAG.53: 2 residues within 4Å:- Chain A: I.791
- Chain C: N.706
Ligand excluded by PLIPNAG.54: 4 residues within 4Å:- Chain C: N.1095, T.1097, H.1098, F.1100
Ligand excluded by PLIPNAG.55: 1 residues within 4Å:- Chain C: N.1131
Ligand excluded by PLIPNAG.56: 7 residues within 4Å:- Chain B: A.341, L.438
- Chain D: I.111
- Chain E: T.32, Y.50, G.51, S.54
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cao, Y. et al., Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75. Cell Host Microbe (2022)
- Release Date
- 2022-10-19
- Peptides
- Spike glycoprotein: ABC
S309 heavy chain: DF
S309 light chain: EG - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HF
IE
FG
G
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.72 Å
- Oligo State
- hetero-3-2-2-mer
- Ligands
- 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 45 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cao, Y. et al., Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75. Cell Host Microbe (2022)
- Release Date
- 2022-10-19
- Peptides
- Spike glycoprotein: ABC
S309 heavy chain: DF
S309 light chain: EG - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HF
IE
FG
G